SALEM INVESTMENT COUNSELORS INC

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 884423 WINSTON-SALEM, NC

Back to BCRX Full portfolio

Position in BCRX

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$2,000

+$482 QoQ

Shares Held

200

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#294

of 316 holders

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

SALEM INVESTMENT COUNSELORS INC holds $1,287,735 across 14 Drug Manufacturers - Specialty & Generic names. BCRX ranks #8 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GLAS	Glass House Brands Inc.	51,133	$664,729
2	VTRS	Viatris Inc	13,446	$213,522
3	DERM	Journey Medical Corp	29,200	$206,736
4	HLN	Haleon plc	9,114	$85,033
5	HROW	Harrow, Inc.	1,300	$55,211
6	ZTS	Zoetis Inc.	586	$42,109
7	HIMS	Hims & Hers Health, Inc.	400	$13,868
8	BCRX	Biocryst Pharmaceuticals Inc This page	200	$2,000

All Filings in BCRX

Export CSV

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,000	200	0.0%	Shares	Sole	2026-07-14
2025-09-30	$1,518	200	0.0%	Shares	Sole	2025-10-07
2025-06-30	$1,792	200	0.0%	Shares	Sole	2025-07-08
2025-03-31	$1,500	200	0.0%	Shares	Sole	2025-04-16
2024-12-31	$1,504	200	0.0%	Shares	Sole	2025-01-13
2024-09-30	$1,520	200	0.0%	Shares	Sole	2024-10-15
2024-06-30	$1,236	200	0.0%	Shares	Sole	2024-07-11
2024-03-31	$1,016	200	0.0%	Shares	Sole	2024-04-11
2023-12-31	$1,198	200	0.0%	Shares	Sole	2024-01-16
2023-09-30	$1,416	200	0.0%	Shares	Sole	2023-10-04
2023-06-30	$1,408	200	0.0%	Shares	Sole	2023-07-19
2023-03-31	$1,668	200	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.